Premium
Management of membranous nephropathy
Author(s) -
Cattran Daniel
Publication year - 2000
Publication title -
nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 61
eISSN - 1440-1797
pISSN - 1320-5358
DOI - 10.1046/j.1440-1797.2000.00026.x
Subject(s) - medicine , membranous nephropathy , nephropathy , reduction (mathematics) , intensive care medicine , blood pressure , pharmacology , glomerulonephritis , endocrinology , kidney , diabetes mellitus , geometry , mathematics
SUMMARY: The Management of membranous nephropathy requires a recognition of its natural history and an ability to predict those pationts with the worst prognosis. Treatment of those at risk of progression with immunosuppressive drugs should be accompanied by additional conservative risk reduction strategies such as dietary protein restriction, blood pressure reduction, angiotensin‐converting enzyme inhibitors and lipid‐lowering agents. Anticoagulants should also be considered as well as medications to reduce drug toxicity.